MedCity News

New FDA Nod Brings Bristol Myers Squibb Cancer Drug to a Wider Range of Solid Tumors

Wheel’s New AI Platform Seeks to Power the New Era of Virtual Care

This week, Wheel rolled out a new AI-powered platform designed to provide patients with more holistic and seamless virtual care journeys. The platform, called Horizon, aims to help the startup’s customers rapidly scale virtual care programs to meet growing patient demand.

By Katie Adams

Payers, Health Tech

Better Health Raises $14M To Reach More Patients with Chronic Conditions

Better Health's $14 million in funding included investments from Healthworx, the University of Miami Health System and Mosaic General Partnership.

By Marissa Plescia

MedCity Influencers

Addressing Healthcare Workforce Shortages Beyond Band-Aids

Solving this problem will require a multi-pronged approach that includes recruitment, technology, and help from lawmakers.

By Charlie Lougheed

Latest News

Payers

Report: MA Beneficiaries Spend $2,500 Less on Healthcare Than Traditional Medicare Beneficiaries

A report conducted by ATI Advisory and commissioned by Better Medicare Alliance found that Medicare Advantage beneficiaries have lower healthcare spending than fee-for-service Medicare enrollees. This is true across racial and ethnic groups, according to the report.

By Marissa Plescia

Pharma BioPharma,

Ipsen, Genfit Drug That Missed in MASH Wins FDA Approval in a Much Rarer Liver Disease

Iqirvo failed as a treatment for the fatty liver disease MASH, but the drug is now FDA approved in primary biliary cholangitis. An Intercept Pharmaceuticals drug already treats this rare liver disease and Gilead Sciences is poised to compete with its PBC drug approaching an FDA decision this summer.

By Frank Vinluan

The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions

In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.

By Impact Brands

MedCity Influencers

How Good Referral Pathways Impact Vascular and Overall Health

As with so many other conditions, in vascular health, patients often need to be seen within a few days or weeks, but current referral systems drag on for many weeks and months.

By Dr. William P. Shutze

Mount Sinai Medical Center Taps HealthSnap to Improve Chronic Conditions Management

South Florida-based Mount Sinai Medical Center announced a new remote patient monitoring and chronic care management partnership with HealthSnap, a Miami-based virtual care management platform. The partnership is aimed at improving outcomes among the health system’s Medicare population.

By Katie Adams

MedCity Influencers

Navigating the Tricky Climate of Health Tech Funding

Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.

By Erin George

Payers

At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program

At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.

MedCity Influencers

How Regulatory Ambiguity is Impeding Healthcare Innovation

America should be a global leader in healthcare. Instead, we rank last among our peers, and outmoded regulations are holding us back.

By Oliver Kharraz

BioPharma, Pharma

Skye Bioscience Falls Short in Glaucoma Trial, But It’s Full Steam Ahead for Obesity Program

Skye Bioscience’s nimacimab blocks CB1, the same receptor targeted by an obesity drug candidate now in the hands of Novo Nordisk. But Skye contends its Phase 2-ready antibody drug has several advantages over the small molecule that joined Novo’s pipeline in a deal valued at $1 billion.

By Frank Vinluan

Partnership Post

When Investment Rhymes with Canada

Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.

By Julien Rosan and Tina Kotrych - Global Affairs Canada

Health Tech

Pelago Launches Inpatient Centers of Excellence Network

Pelago's new Inpatient Centers of Excellence network offers Pelago members access to a nationwide network of inpatient substance use disorder treatment centers. The network includes organizations like the Recovery Centers of America and Banyan Treatment Centers.

By Marissa Plescia

Startups

New Startup Launches to Reduce Medical Practices’ HR Burden

Stitch PEO — a startup built at Redesign Health — officially launched and announced that it has raised $8.75 million in seed funding. The company is a professional employer organization for independent medical practices, designed to improve recruiting, hiring, onboarding, and other human resources processes.

By Katie Adams

BioPharma, Pharma

Moderna’s Flu & Covid-19 Combination Vaccine Succeeds in Phase 3 Clinical Trial

An experimental Moderna combination vaccine for influenza and Covid-19 showed in a pivotal study that it can elicit a higher immune response compared to vaccines that are already available to protect against infection from both viruses.

By Frank Vinluan

MedCity Influencers

Rapid Translation of Therapeutic Discoveries into the Clinic through Purposeful Collaboration

How academia and biotech can team up to bring impactful new drug therapies to patients faster

By Jason Bock and Paul Wotton

MedCity Influencers

Mental Health and Aging: The Role of Primary Care in Overcoming Barriers to Treatment

Physical and mental health are inextricably intertwined — senior-focused primary care can help bridge the treatment gap

By Reneé Buckingham

BioPharma, Pharma

Geron Drug Lands a First-in-Class FDA Approval in Type of Blood Cancer

Geron Corporation’s Rytelo is now FDA approved for treating anemia caused by myelodysplastic syndromes. The new drug will compete against Reblozyl, a blockbuster Bristol Myers Squibb medicine.

By Frank Vinluan

Hospitals, Artificial Intelligence, Providers

What Hospitals Need to Know about Patient Trust in GenAI

Hospitals need to start thinking about ways to build patients’ trust in generative AI in order for the healthcare industry to fully harness the technology’s potential. They can do this through methods like having transparent conversations, asking for patients’ consent to use the tools and training models on internal data, experts said.

By Katie Adams

MedCity Influencers

Closing the MSK Care Gap in Time for the Silver Tsunami

The biggest generation America has ever seen is officially aging and consuming more MSK care as they do so.

By Donovan Campbell